ASX:VITPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
Vitura Health Ltd
$0.025
+$0.001 (+4.17%)
Day Range
$0.025 – $0.025
52 Week Range
$0.021 – $0.072
Volume
60.00
Avg Volume (10D)
229.54K
Market Cap
$16.57M
P/E Ratio
4.40
Price Chart
Market Statistics
Open$0.025
Previous Close$0.024
Day High$0.025
Day Low$0.025
52 Week High$0.072
52 Week Low$0.021
Valuation
Market Cap16.57M
Shares Outstanding662.74M
P/E Ratio (Annual)4.40
P/E Ratio (TTM)20.17
Dividend Yield8.33%
Price to Book0.34
Trading Activity
Volume60.00
Value Traded1.50
Bid$0.025 × 79,940
Ask$0.026 × 100,419
Performance
1 Day-4.00%
5 Day-7.69%
13 Week-35.14%
52 Week-67.57%
YTD-60.66%
Technical Indicators
RSI (14)42.00
50-Day SMA$0.028
200-Day SMA$0.046
Latest News
Biotechnology
Vitura Health's Doctors on Demand on Track for Sustained Profitability as Consultations Surpass 1 Million
VIT hits profitability: Doctors on Demand tops 1 million consultations since FY2024; revenue rises 54% to FY2026 Q1-Q3, EBITDA positive at 5%.
Industrials & Juniors
Vitura Health Signs Online Distribution Deal for MedReleaf Medicinal Cannabis Products
Vitura Health strikes MedReleaf distribution deal, targeting up to $15m extra annual revenue via Canview across 4,700 pharmacies.
Hot Topics
Trump’s CBD Comments Ignite US Cannabis Stocks Surge – Will ASX Companies Follow Suit?
Shares of cannabis and CBD-related companies surged on Monday after US President Donald Trump posted on Truth Social that hemp-derived cannabidiol (CBD), especially in senior healthcare, “could revolutionize” treatment by reducing disease progression and providing an alternative to prescription drugs. He further reiterated his administration is exploring reclassifying marijuana under federal law, a change that could […]